Dialogue Health Technologies Inc. completes C$115M initial public offering
April 15, 2021
115.00 Million CAD
On March 30, 2021, Dialogue Health Technologies Inc. ("Dialogue") completed an initial public offering on the TSX pursuant to which it sold an aggregate of 8,334,000 common shares at a price of C$12 per share, for total gross proceeds of approximately C$100 million.
On April 15, 2021, the over-allotment option granted by certain shareholders of Dialogue to the underwriters to purchase up to an additional 1,250,100 common shares at the offering price was exercised in full. The selling shareholders will receive aggregate gross proceeds of approximately C$15 million in connection with this secondary offering of common shares.
The initial offering and secondary offering were made through a syndicate of underwriters led by National Bank Financial Inc., RBC Capital Markets, Scotiabank and TD Securities Inc. as joint bookrunners and including CIBC World Markets Inc., Desjardins Securities Inc., Canaccord Genuity Corp., iA Private Wealth Inc., INFOR Financial Inc. and Laurentian Bank Securities Inc.
Dialogue is Canada’s premier virtual healthcare and wellness platform, providing affordable, on-demand access to quality care.
McCarthy Tétrault advised a syndicate of underwriters with a team led by Clemens Mayr, Charles-Antoine Soulière and Myreille Gilbert that included Karl Tabbakh, Loïc Sanscartier and Laetitia Ouedraogo (Securities), Marie-Soleil Landry (Tax), Véronique Wattiez Larose (IP), Nicolas Cloutier and Samuel Julien (Regulatory), and Charles Morgan (Privacy).